CARL ZEISS MEDITEC ADR 1 (AFXA) — Free Cash Flow Generation Index
CARL ZEISS MEDITEC ADR 1 (AFXA) has a Free Cash Flow Generation Index of 0.47x as of September 2025. Free cash flow of €67.56 Million represents 0% of operating cash flow (€144.16 Million). See CARL ZEISS MEDITEC ADR 1 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
CARL ZEISS MEDITEC ADR 1 Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for CARL ZEISS MEDITEC ADR 1 across 4 annual periods. Explore CARL ZEISS MEDITEC ADR 1 cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for CARL ZEISS MEDITEC ADR 1 (2022–2025)
Year-by-year Free Cash Flow Generation Index for CARL ZEISS MEDITEC ADR 1. For the full company profile including market capitalisation, see CARL ZEISS MEDITEC ADR 1 (AFXA) market capitalisation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | €133.26 Million | €209.86 Million | €76.59 Million | ▲ +65.1% |
| 2024 | 0.38x | €95.11 Million | €247.32 Million | €152.20 Million | ▼ -29.6% |
| 2023 | 0.55x | €137.00 Million | €250.86 Million | €113.86 Million | ▼ -3.2% |
| 2022 | 0.56x | €106.23 Million | €188.20 Million | €81.97 Million | — |